Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International Cooperative Phase III Trial of the HIT-HGG Study Group for the Treatment of High Grade Glioma, Diffuse Intrinsic Pontine Glioma, and Gliomatosis Cerebri in Children and Adolescents < 18 Years.(HIT-HGG-2013)

NCT03243461 is registered in ClinicalTrials.gov with University of Göttingen as lead sponsor.

NCT NCT03243461
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03243461 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International Cooperative Phase III Trial of the HIT-HGG Study Group for the Treatment of High Grade Glioma, Diffuse Intrinsic Pontine Glioma, and Gliomatosis Cerebri in Children and Adolescents < 18 Years.(HIT-HGG-2013)
Lead sponsor
University of Göttingen
Phase
Phase 3
Overall status
Unknown status
Start date
July 17, 2018
Completion date
December 31, 2023
Enrollment
167 (estimated)
Sites
51

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic astrocytoma who grade iii, diffuse intrinsic pontine glioma, diffuse midline glioma histone 3 k27m who grade iv, glioblastoma who grade iv, gliomatosis cerebri